Biocon informs about outcome of board meeting

06 Dec 2025 Evaluate
Further to intimation dated December 03, 2025 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015), Biocon has informed that the Board of Directors of Biocon at its meeting held today, i.e. on December 06, 2025 has transacted the following business: Increase in Authorised Share Capital and consequential amendment to the Memorandum of Association of the Company; Acquisition of equity shares of Biocon Biologics Limited and issuance of equity shares on a preferential basis; Fund Raising; Convening of Extra-Ordinary General Meeting (EGM); and Issuance of Commercial Papers. The above-mentioned information will also be available on the website of the Company at www.biocon.com. Further, the Board Meeting commenced at 8:55 AM and concluded at 9:20 AM.

The above information is a part of company’s filings submitted to BSE. 

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×